Antioxidant capacity of the neurohormone melatonin

Journal of Neural Transmission

Volumn 112, Issue 3, 2005, Pages 349-358

  Sofic, E ^a,b,c   Rimpapa, Z ^c   Kundurovic, Z ^c   Sapcanin, A ^c   Tahirovic, I ^c   Rustembegovic, A ^d   Cao, G ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^d Anton Proksch Institute   (Austria)

Author keywords

Antioxidant; Hydroxyl radical; Melatonin; Neutral red radical; Oxygen radical absorbance capacity (ORAC); Peroxyl radical; Photolysis of neutral red; Photosensitizer; Transition metal

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; COPPER ION; GLUTATHIONE; HYDROXYL RADICAL; MELATONIN; NEUROHORMONE; NEUTRAL RED; OXYGEN RADICAL; PEROXY RADICAL; PHYCOERYTHRIN; PORPHYRIN DERIVATIVE; TRANSITION ELEMENT; TROLOX C;

ABSORPTION; AEROBIC METABOLISM; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CELL PROTECTION; FLUORESCENCE ANALYSIS; HORMONE ACTION; HORMONE RELEASE; INHIBITION KINETICS; LIPID SOLUBILITY; OXIDATIVE STRESS; PHOTOCHEMICAL QUENCHING; PHOTOLYSIS; PINEAL GLAND FUNCTION; PRIORITY JOURNAL; ROOM TEMPERATURE; SLEEP WAKING CYCLE; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET RADIATION;

ANTIOXIDANTS; HUMANS; MELATONIN; NEUROTRANSMITTER AGENTS; REACTIVE OXYGEN SPECIES;

EID: 20944434321     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-004-0270-4     Document Type: Article

References (31)

1. Al-Hassan LA (1995) Photoinduced reactions of neutral red with cyclohexanone. J Photochem Photobiol A: Chemistry 89: 235-238
2. Al-Hassan LA, Al-Amro FS (1998) Photolytic and photosensitized reduction of neutral red under VIS radiation. J Photochem Photobiol A: Chemistry 119: 205-212
3. Ames BN, Shigenaga MK, Hagen TM (1993) Oxidants and the degenerative disease of aging. Proc Natl Acad Sci USA 90: 7915-7922
4. Chase JE, Gldal BE (1997) Melatonin: therapeutic use in sleep disorders. Ann Pharmacother 31: 1218-1226
5. Cicone DC (1998) Free radical toxicity and antioxidant medications in Parkinson's disease. Phys Ther 78: 313-319
6. Cohen G, Werner P (1994) Free radicals, oxidative stress, and neurodegeneration. In: Calne DB (ed) Neurodegenerative diseases. WB Saunders, Philadelphia, pp 139-162
7. Ebadi M, Srinivasan SK, Baxi MD (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Prog Neurobiol 48: 1-19
8. Halliwell B (1992) Reactive oxygen species and the control nervous system. J Neurochem 59: 1609-1623
9. Halliwell B, Gutteridge JM (1984) Oxygen toxicity, oxygen radicals, transition metals and diseases. Biochem J 219: 1-14
10. Kabuto H, Yokoi I, Ogawa N (1998) Melatonin inhibits iron-induced epileptic discharges in rats by suppressing peroxidation. Epilepsia 39: 237-243
11. Kundurovic Z, Scepovic M, Causevic A, Mornjakovic Z (1991) Histochemical aspects and fine structural characteristics of thyreocytes in pinealectomized and melatonin treated rats prior to irradiation. Acta Med Croat 45: 347-355
12. Lin AMY, Ho LT (2000) Melatonin suppresses iron-induced neurodegeneration in rat brain. Free Radic Biol Med 28: 904-911
13. Marks GT, Lee ED, Aikens DA, Richtol HH (1984) Transient photochemistry of neutral red. Photochem Photobiol 39(3): 323-328
14. Marsden CD, Olanow CW (1998) The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality. Ann Neurol 44: 189-196
15. Nunnari G, Nigro L, Palermo F, Leto D, Pomerantz RJ, Cacopardo B (2003) Reduction of serum melatonin levels in HIV-1-infected individuals parallel disease progression: correlation with serum interleukin-12 levels. Infection 31: 379-382
16. Olanow CW (1992) An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol 32: S2-S9
17. Pieri C, Marra M, Moroni F, Recchioni R, Marccheselli F (1994) Melatonin: a peroxyl radical scavenger more effective than vitamin E. Pharmacol Lett 55: 271-276
18. Quay WB, Kachi T (1995) Amine-secreting endocrines. In: Timiras PS, Quay WB, Verndakis A (eds) Hormones and aging. CRC Press, Boca Raton New York London Tokyo, pp 67-84
19. Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56: 359-384
20. Reiter RJ (2003) Melatonin: clinical relevance. Best Pract & Res Clin Endocrinol Metabol 17(2): 273-285
21. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brain. J Neurochem 52(2): 515-520
22. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, Reiter RJ (2004) Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36: 1-9
23. Simom DK, Standaert DG (1999) Neuroprotective therapies. Med Clin North Am 83: 509-523
24. Sofic E, Denisova N, Youdim K, Vatrenjak-Velagic V, De Filippo C, Mehmedagic A, Causevic A, Cao G, Joseph JA, Prior RL (2001) Antioxidant and pro-oxidant capacity of catecholamines and related compounds. Effects of hydrogen peroxide on glutathione and sphingomyelinase activity in pheochromocytoma PC12 cells: potential relevance to age-related diseases. J Neural Transm 108: 541-557
25. Sofic E, Rustembegovic A, Kroyer G, Cao G (2002) Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm 109: 711-719
26. Song JS (1999) Preliminary observations on the effect of photodynamic therapy on bone resorption in mouse calvaria organ cultures using neutral red as the photosensitizer. Thesis, Harvard School of Dental Medicine, Boston, MA, p 4
27. Tan D, Reiter RJ, Chen LD, Poeggler B, Manchester LC, Barlow-Walden LR (1994) Both physiological and pharmacological levels of melatonin reduced DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15: 215-218
28. Tan DX, Chen LD, Poeggler B, Manchester LC, Reiter RJ (1993) Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrinol J 1: 57-60
29. Taysi S, Koc M, Buynkuroglu ME, Altinkaynak K, Sahin YN (2003) Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in the rat liver. J Pineal Res 34(3): 173-177
30. Thomas B, Mohanakumar KP (2004) Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum. J Pineal Res 36: 25-32
31. Vijayalaxmi, Reiter RJ, Sewerynek E, Poeggler B, Leal BZ, Meltz ML (1995) Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radiat Res 143: 102-106